'Real-world' Australian experience of pomalidomide for relapsed and refractory myeloma

Toxicity-Related Treatment Cessation in Newly Diagnosed Multiple Myeloma-Risk Factors and Survival: An Analysis From the APAC and ANZ Myeloma and Related Diseases Registry.

European journal of haematology·2026

Gilteritinib plus azacitidine in patients with newly diagnosed FLT3 mutation-positive acute myeloid leukemia who were ineligible for intensive chemotherapy: final results of the phase III LACEWING study.

Haematologica·2026

LTB-TREAT: A validated international prognostic model for time to treatment in low tumour burden follicular lymphoma.

British journal of haematology·2026

Daratumumab, lenalidomide, and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: MAIA final survival analysis.

Leukemia·2026

Allogeneic stem cell transplantation for mantle cell lymphoma can achieve durable remission and myeloablative conditioning is associated with inferior survival: an Australian and New Zealand Transplant & Cellular Therapies registry study.

Internal medicine journal·2026

Climate hazards and mental health hospitalizations in China: socioeconomic disparities, demographic drivers, and adaptation - a nationwide population-based study.

The Lancet regional health. Western Pacific·2026

Prognostic factors and survival in HHV8 positive diffuse large B cell lymphoma: a national cancer database analysis.

Leukemia & lymphoma·2026

Adverse events, quality of life, and work impairment in patients with chronic myeloid leukemia (CML)-a survey of first- and second-line tyrosine kinase inhibitor (TKI) intolerance in the US.

Leukemia & lymphoma·2026

Usefulness of 20-mm incisional random skin biopsy for diagnosis of intravascular large B-cell lymphoma: a single-center experience.

Leukemia & lymphoma·2026

MRD-guided induction-intensification with daratumumab-carfilzomib-based regimen followed by ASCT in patients with newly diagnosed multiple myeloma.

Leukemia & lymphoma·2026

Revisiting invasive fungal infections in acute lymphoblastic leukemia: a systematic review and meta-analysis.

Leukemia & lymphoma·2026

Hypereosinophilic syndrome and suspected myeloid neoplasia in relapsed Hodgkin lymphoma during immune checkpoint inhibitor therapy: a rare case.

Leukemia & lymphoma·2026

Utility of Small Dose Pilsicainide in Suppressing Atrial Fibrillation and Inducing a Target Slow-Fast AVNRT.

JACC. Case reports·2026

Efficacy and Safety of Inhaled and Sublingual Apomorphine for On‑Demand Treatment of OFF Episodes in Parkinson Disease: A Systematic Review and Meta-Analysis With Exploratory Network Comparison.

Clinical neuropharmacology·2026

Dangers of Injectable Peptides and Other Unregulated "Biohacking" Drugs.

Missouri medicine·2026

Design and Evaluation of PLGA-Based Hybrid Nanoparticles for Nasal Paclitaxel Delivery: Formulation Optimization, Barrier Transport, and Cytotoxicity Assessment.

ACS omega·2026

Dose-related propofol resistance in COVID-19 patients: Altered drug plasma levels, mechanistic insights from neuronal-derived extracellular vesicles and miRNA analysis.

British journal of clinical pharmacology·2026

Short-Term Efficacy of Tegoprazan Compared With Esomeprazole in Patients With Non-Erosive Reflux Disease and Nocturnal Heartburn Symptoms: A Double-Blind, Randomized Controlled Trial.

The Korean journal of helicobacter and upper gastrointestinal research·2026

Related Experiment Videos

'Real-world' Australian experience of pomalidomide for relapsed and refractory myeloma

Related Concept Videos

Toxicity-Related Treatment Cessation in Newly Diagnosed Multiple Myeloma-Risk Factors and Survival: An Analysis From the APAC and ANZ Myeloma and Related Diseases Registry.

Gilteritinib plus azacitidine in patients with newly diagnosed FLT3 mutation-positive acute myeloid leukemia who were ineligible for intensive chemotherapy: final results of the phase III LACEWING study.

LTB-TREAT: A validated international prognostic model for time to treatment in low tumour burden follicular lymphoma.

Daratumumab, lenalidomide, and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: MAIA final survival analysis.

Allogeneic stem cell transplantation for mantle cell lymphoma can achieve durable remission and myeloablative conditioning is associated with inferior survival: an Australian and New Zealand Transplant & Cellular Therapies registry study.

Climate hazards and mental health hospitalizations in China: socioeconomic disparities, demographic drivers, and adaptation - a nationwide population-based study.

Prognostic factors and survival in HHV8 positive diffuse large B cell lymphoma: a national cancer database analysis.

Adverse events, quality of life, and work impairment in patients with chronic myeloid leukemia (CML)-a survey of first- and second-line tyrosine kinase inhibitor (TKI) intolerance in the US.

Usefulness of 20-mm incisional random skin biopsy for diagnosis of intravascular large B-cell lymphoma: a single-center experience.

MRD-guided induction-intensification with daratumumab-carfilzomib-based regimen followed by ASCT in patients with newly diagnosed multiple myeloma.

Revisiting invasive fungal infections in acute lymphoblastic leukemia: a systematic review and meta-analysis.

Hypereosinophilic syndrome and suspected myeloid neoplasia in relapsed Hodgkin lymphoma during immune checkpoint inhibitor therapy: a rare case.

Utility of Small Dose Pilsicainide in Suppressing Atrial Fibrillation and Inducing a Target Slow-Fast AVNRT.

Efficacy and Safety of Inhaled and Sublingual Apomorphine for On‑Demand Treatment of OFF Episodes in Parkinson Disease: A Systematic Review and Meta-Analysis With Exploratory Network Comparison.

Dangers of Injectable Peptides and Other Unregulated "Biohacking" Drugs.

Design and Evaluation of PLGA-Based Hybrid Nanoparticles for Nasal Paclitaxel Delivery: Formulation Optimization, Barrier Transport, and Cytotoxicity Assessment.

Dose-related propofol resistance in COVID-19 patients: Altered drug plasma levels, mechanistic insights from neuronal-derived extracellular vesicles and miRNA analysis.

Short-Term Efficacy of Tegoprazan Compared With Esomeprazole in Patients With Non-Erosive Reflux Disease and Nocturnal Heartburn Symptoms: A Double-Blind, Randomized Controlled Trial.

Related Experiment Videos

'Real-world' Australian experience of pomalidomide for relapsed and refractory myeloma

Related Concept Videos

Related Articles